Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/1995
12/07/1995CA2190862A1 Post exposure prevention of hiv
12/06/1995EP0685442A1 Reagent and process for the Synthesis of esters and transesterifiable xanthates
12/06/1995EP0685425A1 Process for the preparation of magnesium hydride
12/06/1995EP0684953A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
12/06/1995EP0496749B1 Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
12/05/1995US5473063 Reacting 2,3-epoxy-butanediol/1,4-/(having protected hydroxyl groups) with an alpha allylic nucleophile yields 2-hydroxy-3-allyl-1,4-butanediol, then oxidatively cleaving the double bond, cyclization, halogenation, acetylation or oxyalkylation
12/05/1995US5472949 N4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine compounds, compositions and methods of using same
12/05/1995US5472947 Application of 4-carbamoyl-1-β-D-ribofuranosyl imidazolium-5-olate to the treatment of multiple sclerosis
12/05/1995US5472841 Methods for identifying nucleic acid ligands of human neutrophil elastase
11/1995
11/30/1995WO1995032305A1 Pna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis
11/30/1995WO1995032212A1 Process for producing arabino-nucleosides
11/30/1995WO1995032002A1 Covalent microparticle-drug conjugates for biological targeting
11/30/1995CA2189130A1 Process for producing arabino-nucleosides
11/29/1995EP0683789A1 N-alkyl-2-substituted atp analogues
11/29/1995EP0586523A4 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/28/1995US5470967 Oligonucleotide analogs with sulfamate linkages
11/28/1995US5470953 Human β2 integrin α subunit
11/28/1995US5470858 Derivatives of (hetero)aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them
11/28/1995US5470838 Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
11/28/1995US5470837 Autoimmune disease
11/23/1995WO1995031469A1 Pteridine nucleotide analogs as fluorescent dna probes
11/23/1995WO1995031434A1 Complementary dna and toxins
11/23/1995WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules
11/23/1995DE4418474A1 Verfahren zur Herstellung von Arabinonucleosiden A process for preparing Arabinonucleosiden
11/23/1995CA2190145A1 Complementary dna and toxins
11/22/1995EP0683171A1 A process for the preparation of beta-thymidine
11/22/1995EP0682670A1 Deoxygenation of cis vicinal diols
11/22/1995EP0682519A1 Adenosine kinase inhibitors
11/22/1995CN1112123A 5-methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T)
11/22/1995CN1112119A 13-substituted milbemycin derivatives, their preparation and use
11/21/1995US5468853 Synthesis of 5-radiohalo-2'-deoxyuridine
11/21/1995US5468849 Rebeccamycin analogs by tryptophan analogs feeding
11/21/1995US5468771 A tricarboxy-dioxabicyclooctane
11/16/1995WO1995030775A1 High-affinity ligands of insulin receptor antibodies, tachykinin substance p, hiv integrase and hiv-1 reverse transcriptase
11/16/1995WO1995030683A1 Adenosine derivatives
11/16/1995WO1995030682A1 Antitumor indolopyprolocarbazole derivative
11/16/1995CA2186847A1 Adenosine derivatives
11/15/1995EP0484333B1 Nucleoside derivatives and their use as medicaments
11/15/1995CN1111639A Liponucleotide compounds
11/14/1995US5466793 Catalytic reducing of a nucleoside with hydrogen in the presence of palladium and recovering
11/14/1995US5466787 Process for preparing AZT
11/14/1995US5466786 2'modified nucleoside and nucleotide compounds
11/14/1995US5466679 Carboranyl uridines and their use in boron neutron capture therapy
11/14/1995US5466678 Potentiating antitumor activity
11/14/1995US5466677 Dinucleoside phosphinates and their pharmaceutical compositions
11/14/1995US5466450 From Kibdelosporangium, treatment of herpes simplex
11/09/1995WO1995029930A2 Improved method for oligonucleotide analog synthesis
11/08/1995EP0680969A2 Modified oligonucleotides, their preparation and their use
11/08/1995EP0680968A1 Method for the preparation of ginkgolide B from ginkgolide C
11/08/1995EP0680488A1 2,6-diaminopurine derivatives
11/08/1995CN1111249A TTTr as protective group in nucleotide synthesis
11/07/1995US5464826 Antitumor, anticarcinogenic agents, treatment of herpes
11/03/1995CA2148312A1 Modified oligonucleotides, their preparation and their use
11/02/1995WO1995029184A1 Polycationic nucleic bases and oligonucleotides containing same
11/02/1995EP0679657A2 Nucleosides and oligonucleotides containing 2'-ether groups
11/02/1995EP0679196A1 Dna sequencing by mass spectrometry
11/02/1995EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/02/1995EP0562047A4 Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
10/1995
10/31/1995US5463092 Viricides
10/31/1995US5463035 Precipitation, chromatography using strongly basic anion exchange resin in borate form, crystallization
10/31/1995US5462929 Treatment of psoriasis by administration of 4-carbamoyl-1-β-D-ribofuranosylimidszolium-5-oleate
10/28/1995CA2147798A1 Nucleosides and oligonucleotides having 2'-ether groups
10/26/1995WO1995028160A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/24/1995US5461168 Processes for the production of 13-ether derivatives of milbemycins, and intermediates therefor
10/24/1995US5461055 Fungicides
10/24/1995US5461036 Treating colon, gastric, esophageal cancer
10/18/1995EP0677054A1 New antiparasitic agents related to the milbemycins and avermectins
10/17/1995US5459256 Lipophilic, aminohydrolase-activated prodrugs
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459254 Reversing the order of the amination and alkynylation steps
10/17/1995US5459132 N6-[(Imidazo[1,2-a]pyridin-3-yl)ethyl]adenosines, their 5'-uronamide analogues and pharmaceutical compositions
10/17/1995US5459015 High-affinity RNA ligands of basic fibroblast growth factor
10/17/1995CA2037783C Rebeccamycin analogs by tryptophan analogs feeding
10/15/1995CA2163890A1 Dc-89 derivative
10/12/1995WO1995026972A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995WO1995026971A1 Cyclic nucleotide derivative
10/12/1995CA2186250A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/11/1995EP0675896A1 Purine derivatives
10/11/1995CN1109755A Antiviral, Highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate 2',3',-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
10/11/1995CN1029974C Novel alpha-glucosidase inhibitors
10/11/1995CN1029972C Selective adenosine receptor compounds
10/11/1995CN1029968C Process for preparation of N-heteroaryl-purin-6-amines and their use as medicaments
10/10/1995US5457191 3-deazapurines
10/10/1995US5457111 Macrocyclic immunomodulators
10/04/1995EP0675133A1 13-Substituted milbemycin derivatives, their preparation and use
10/04/1995EP0674647A1 Analytical technique for oligonucleotide analogs.
10/04/1995EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/1995EP0674529A1 Lipid prodrugs for oral administration
10/03/1995US5455339 Method for the preparation of 2',3'-dideoxy and 2',3'-dideoxydide-hydro nucleosides
09/1995
09/28/1995WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
09/27/1995EP0673947A1 Psicofuranose and psicopyranose derivatives
09/26/1995US5453497 Process for producing N4 -acyl-5'-deoxy-5-fluorocytidine compounds
09/26/1995US5453496 Polynucleotide phosphorodithioate
09/21/1995WO1995025115A1 Process for producing sialic acid derivative and novel sialic acid derivative
09/21/1995WO1995019974A3 Calixarene-based compounds having antibacterial, antifungal, anticancer-hiv activity
09/20/1995EP0672418A2 Use of adenosine monophosphate deaminase inhibitor for increasing extracellular adenosine
09/20/1995EP0364559B1 Substituted adenine derivatives useful as therapeutic agents
09/20/1995CN1108660A Technology for production of adenosine triphospharic acid (ATP) by using adenosine (AR) as raw material
09/19/1995US5451671 Solvent extraction, crystallization, adsorption on porous resin
09/19/1995US5451663 Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates